This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat ...